House lawmakers advanced the bill to cap insulin and related medical supplies at $25 per month each with a 59-27 vote.

No treatment or drug gets to market without a clinical trial. Many of those trials don’t just happen in academic settings, ...

Artificial sweeteners like aspartame have long been promoted as a healthier alternative to sugar, allowing people to enjoy ...

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 17.2% year on year to $597.5 million. Guidance for next ...

Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps.

Looking ahead, Insulet provided a strong outlook for 2025, projecting total revenue growth of 16% to 20% in constant currency. The company expects U.S. Omnipod revenue to grow 16% to 20% and ...

Overeating disrupts hormone balance, leading to infertility in both men and women. Excess weight causes hormonal imbalances ...

With the rate of diabetes growing worldwide, it can feel like the condition is tough to avoid. A large Japanese study reveals ...

A shocking new study has suggested a common artificial sweetener could increase the risk of heart attacks and strokes, with ...

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...